Statins may provide some relief for endocrine therapy-resistant breast cancer according to a study conducted by Liang et al. When simvastatin and tamoxifen, a selective estrogen receptor modulator, are combined in tamoxifen-resistant xenografted mice models, tumor size, weight, and volume were markedly reduced compared to placebo mice. This evidence concerns the gene ESR1 and breast cancer.